MVA Investors, LLC is Director & 10% Owner at iTeos Therapeutics, Inc. (ITOS). They have made 9 open-market trades across 5 companies since 2013, most recently 2024-07-02.
CIK 0001468223
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $12.0M since 2013, against 6 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 67% | 33% |
| Avg Move | +5.5% | +3.9% | +28.2% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNGX | SELL | 2024-06-28 | 2024-07-02 | $8.79 | $3.0M | +25.4% | +18.3% | -3.6% |
| TNGX | SELL | 2024-06-06 | 2024-06-07 | $7.04 | $986K | +41.3% | +31.4% | +72.8% |
| TNGX | SELL | 2024-05-01 | 2024-05-03 | $7.53 | $1.6M | +2.6% | -7.9% | +24.3% |
| TNGX | SELL | 2023-10-09 | 2023-10-11 | $9.96 | $2.2M | -18.7% | -3.6% | +8.0% |
| TNGX | BUY | 2023-08-11 | 2023-08-15 | $5.15 | $2.4M | +1.6% | +18.1% | +8.5% |
| MRTX | BUY | 2023-08-11 | 2023-08-15 | $27.80 | $1.6M | -6.6% | -16.7% | +41.9% |
| ITOS | SELL | 2022-01-03 | 2022-01-05 | $46.54 | $65.1M | -8.4% | -13.3% | -17.2% |
| EBIO | SELL | 2016-06-13 | 2016-06-14 | $2.74 | $5.7M | -9.3% | -1.7% | +85.2% |
| SPHS | BUY | 2013-08-16 | 2013-08-20 | $5.00 | $8.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.